Terms: = Testicular cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
21 results:
1. Effect of Aprepitant on Etoposide Pharmacokinetics in Patients with testicular cancer: A Pharmacokinetic Study to Determine the Absence of a Clinically Relevant Interaction.
Strik J; de Jong LAW; Sijm J; Desar IME; van Erp NP
Clin Pharmacol Ther; 2024 Jan; 115(1):135-138. PubMed ID: 37867292
[TBL] [Abstract] [Full Text] [Related]
2. Identifying and prioritizing educational content from a malpractice claims database for clinical reasoning education in the vocational training of general practitioners.
van Sassen CGM; van den Berg PJ; Mamede S; Knol L; Eikens-Jansen MP; van den Broek WW; Bindels PJE; Zwaan L
Adv Health Sci Educ Theory Pract; 2023 Aug; 28(3):893-910. PubMed ID: 36529764
[TBL] [Abstract] [Full Text] [Related]
3. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
Conduit C; Koh TT; Hofman MS; Toner GC; Goad J; Lawrentschuk N; Tai KH; Lewin JH; Tran B
Cancer Imaging; 2022 Oct; 22(1):58. PubMed ID: 36209121
[TBL] [Abstract] [Full Text] [Related]
4. Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists.
Al Dahmani KM; Almalki MH; Ekhzaimy A; Aziz F; Bashier A; Mahzari MM; Beshyah SA
Pituitary; 2022 Aug; 25(4):658-666. PubMed ID: 35793046
[TBL] [Abstract] [Full Text] [Related]
5. testicular FDG Uptake on PET/CT in Patients with Lymphoma: Correlation with Age.
Khessib T; Itani M; Hippe D; Akaike G; Bermo M; Zare M; Behnia F
Curr Probl Diagn Radiol; 2022; 51(4):474-477. PubMed ID: 34756775
[TBL] [Abstract] [Full Text] [Related]
6. Tumor markers and
Dondi F; Albano D; Bertagna F; Giubbini R
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):287-292. PubMed ID: 34425969
[TBL] [Abstract] [Full Text] [Related]
7. 18F-Flourodeoxy glucose PET-computed tomography in testicular carcinoma: diagnostic and prognostic value.
Soydal C; Araz M; Urun Y; Gulpinar B; Nak D; Ozkan E; Kucuk NO
Nucl Med Commun; 2019 Dec; 40(12):1268-1274. PubMed ID: 31568190
[TBL] [Abstract] [Full Text] [Related]
8. Functional Parameters of
Yang J; Zhu S; Pang F; Xu M; Dong Y; Hao J; Ma X
Contrast Media Mol Imaging; 2018; 2018():8659826. PubMed ID: 30363729
[TBL] [Abstract] [Full Text] [Related]
9. Retrospective analysis of patients with relapsed or refractory testicular nonseminous germ cell tumors treated with autologous stem cell transplantation.
Yilmaz F; Soyer N; Uslu R; Erdogan AP; Karaca B; Saydam G; Sahin F; Vural F
Indian J Cancer; 2017; 54(2):415-420. PubMed ID: 29469069
[TBL] [Abstract] [Full Text] [Related]
10. The primitive extratesticular seminoma: diagnosis of a rare pathology.
Saba L
Acta Biomed; 2017 Apr; 88(1):82-85. PubMed ID: 28467339
[TBL] [Abstract] [Full Text] [Related]
11. Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI.
El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
Eur J Radiol; 2016 Nov; 85(11):2072-2082. PubMed ID: 27776661
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of Metastatic Seminomatous testicular Tumor with Complicated Diagnosis by FDG-PET].
Hashizume A; Mizuno N; Kawai M; Kishida T
Hinyokika Kiyo; 2016 Jul; 62(7):383-7. PubMed ID: 27569358
[TBL] [Abstract] [Full Text] [Related]
13. Expression of neural cell adhesion molecule L1 (CD171) in neuroectodermal and other tumors: An immunohistochemical study of 5155 tumors and critical evaluation of CD171 prognostic value in gastrointestinal stromal tumors.
Inaguma S; Wang Z; Lasota JP; Miettinen MM
Oncotarget; 2016 Aug; 7(34):55276-55289. PubMed ID: 27419370
[TBL] [Abstract] [Full Text] [Related]
14. The Validity and Reliability of Health Belief Scale for testicular cancer Self-Examination.
Avci IA; Altinel B
Am J Mens Health; 2018 May; 12(3):531-538. PubMed ID: 26483292
[TBL] [Abstract] [Full Text] [Related]
15. Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2/1).
Schwartz GK; LoRusso PM; Dickson MA; Randolph SS; Shaik MN; Wilner KD; Courtney R; O'Dwyer PJ
Br J Cancer; 2011 Jun; 104(12):1862-8. PubMed ID: 21610706
[TBL] [Abstract] [Full Text] [Related]
16. Testosterone production is better preserved after 16 than 20 Gray irradiation treatment against testicular carcinoma in situ cells.
Bang AK; Petersen JH; Petersen PM; Andersson AM; Daugaard G; Jørgensen N
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):672-6. PubMed ID: 19250763
[TBL] [Abstract] [Full Text] [Related]
17. High-intensity strength training improves quality of life in cancer survivors.
De Backer IC; Van Breda E; Vreugdenhil A; Nijziel MR; Kester AD; Schep G
Acta Oncol; 2007; 46(8):1143-51. PubMed ID: 17851864
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17).
Dearnaley DP; Fossa SD; Kaye SB; Cullen MH; Harland SJ; Sokal MP; Graham JD; Roberts JT; Mead GM; Williams MV; Cook PA; Stenning SP;
Br J Cancer; 2005 Jun; 92(12):2107-13. PubMed ID: 15928672
[TBL] [Abstract] [Full Text] [Related]
19. Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1.
Qian YM; Song WC; Cui H; Cole SP; Deeley RG
J Biol Chem; 2001 Mar; 276(9):6404-11. PubMed ID: 11102445
[TBL] [Abstract] [Full Text] [Related]
20. [Carboplatin monotherapy in clinical stage I of seminoma. An acceptable alternative?].
Nöst G; Lipsky H; Würnschimmel E
Urologe A; 1998 Nov; 37(6):629-34. PubMed ID: 9887492
[TBL] [Abstract] [Full Text] [Related]
[Next]
